“Bimekizumab Infection Rates in Patients With Moderate to Severe Plaque Psoriasis: Analysis of Pooled Data from 2 Years of Treatment in Phase 3 and 3b Clinical Trials”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s72, https://doi.org/10.25251/skin.6.supp.72.